Raw Steroid Powder Ethinylestradiol / Ethynyl Estradiol 57-63-6 For Treatment Of Female Hypogonadism

bargain

Quick Deails

Product name	Ethinylestradiol
CAS No.	57-63-6
Chemical Name	NOVESTROL; NEO-ESTRONE; ETHYNYLESTRADIOL
Molecular Weight	296.41
Molecular Formula	C20H24O2
Purity	99%
Usage	A synthetic steroid with high oral estrogenic potency
Standard	USP28
Appearance	White or almost white crystalline powder
Package	1kg/aluminium foil bag or as your request
Payment	T/T,Western Union,Bitcoin,Money Gram,ect.
Delivery	After payment 3-7days

Abstract

Ethinyl Estradiol is absorbed in the small intestine and reaches a serum peak about 2 hours later. It undergoes extensive metabolism in the liver involving the cytochrome P450 3A4 isoenzyme.
Ethinyl Estradiol and its metabolites are excreted with the bile. Due to the effect of entero hepatic circulation a second peak is seen several hours later. Individually, wide variations exist in the overall absorption process, and can be further modified by drugs that affect the enterohepatic circulation or liver enzymes.
In circulation Ethinyl Estradiol is almost fully bound to plasma albumin. It is metabolized by hydroxylation of the aromatic ring and excreted in both feces and urine, in part as glucuronide and sulfate conjugate.
Ethinyl Estradiol is hormonally effective by activating the estrogen receptor and thus is an estrogen. It finds its most common use in the estrogen-progestin combination preparations of oral contraceptives. Over time, formulations have decreased the Ethinyl Estradiol dose from as high as 100 μg to as low as 10 μg in

Specification

Item	Specification	Results
Appearance	White to creamy white, odorless, crystalline powder.	white crystalline powder
Solubility	Insoluble in water; soluble in alcohol, in chloroform, in ether, in vegetable oils, and in solutions of fixed alkali hydroxides.	Conforms
Identification	A:IR B:UV	Conforms
Specific optical rotation	-28°~ -29.5°	-28.3°
Melting range	180~186ºC	182.5~185.3ºC
Loss on drying	≤1.0%	0.45%
Residual Solvents	Acetone≤0.5%	0.08%
Assay	97.0~102.0% (on the dried basis)	99.43%
Particle Size	90% ≤10μ	Conforms
Conclusion	The product complies with specification in USP34

Application
As Estinyl, EE2 was formerly used for hormone replacement therapy in menopause and the treatment of femalehypogonadism, loss of menstruation, dysmenorrhea, acne, prostate cancer, and breast cancer. However, in more recent times, EE2 is mainly used in COCs. In contraception, due to concerns of unopposed estrogen action and the possible increased risk of endometrial cancer that accompanies this, EE2 is formulated in combination with progestins. EE2 is little used in menopausal hormone replacement therapy.

EE2 has been used at very high dosages (1-2 mg/day) in the treatment of prostate cancer.

Skype&Whatsapp:86 13690838732

Email: ycsales12@ycphar.com